NCT03347357View on ClinicalTrials.gov

Pharmacokinetics of Tacrolimus in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Nephrotic Syndrome
Interventions
DRUG

Tacrolimus

Tacrolimus was administered orally at a dose of 0.05 mg/kg/dose twice daily (bid) for children with nephrotic syndrome.

All Listed Sponsors
lead

Shandong University

OTHER

NCT03347357 - Pharmacokinetics of Tacrolimus in Children | Biotech Hunter | Biotech Hunter